The Company continues to focus its efforts on ensuring its vaccine is available during the pandemic where people are most in need. ![]() The Johnson & Johnson COVID-19 vaccine plays a crucial role in the global fight to end the COVID-19 pandemic. Johnson & Johnson continues to collaborate with health authorities and regulators around the world to ensure healthcare professionals and individuals are warned and fully informed about reports of TTS, enabling correct diagnosis, appropriate treatment, and expedited reporting. Centers for Disease Control and Prevention (CDC) in December 2021 that express a clinical preference for individuals to receive an mRNA COVID-19 vaccine.ĭata continue to support a favorable benefit-risk profile for the Johnson & Johnson COVID-19 vaccine in adults, when compared with no vaccine. This is consistent with the Advisory Committee on Immunization Practices (ACIP) recommendations by the U.S. for use in individuals 18 years of age and older for whom other FDA-authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, as well as for individuals 18 years of age and older who elect to receive the Johnson & Johnson COVID-19 vaccine because they would otherwise not receive a COVID-19 vaccine. Language about the risk of TTS has been added to the first page of the Fact Sheet to increase its prominence.įollowing the update to the Fact Sheet, the Johnson & Johnson COVID-19 vaccine is now authorized in the U.S. COVID-19 Vaccine Fact Sheet to increase awareness about the risk of thrombosis with thrombocytopenia syndrome (TTS), a rare but potentially life-threatening condition. ![]() Food and Drug Administration (FDA), has updated its U.S. Johnson & Johnson, in close coordination with the U.S. NEW BRUNSWICK, NJ, Our number one priority is the safety and well-being of those who use the Johnson & Johnson COVID-19 vaccine.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |